enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Prolactin modulator - Wikipedia

    en.wikipedia.org/wiki/Prolactin_modulator

    Prolactin inhibitors are mainly used to treat hyperprolactinemia (high prolactin levels). [1] Agonists of the dopamine D 2 receptor such as bromocriptine and cabergoline are able to strongly suppress pituitary prolactin secretion and thereby decrease circulating prolactin levels, and so are most commonly used as prolactin inhibitors. [1]

  3. Dopamine agonist - Wikipedia

    en.wikipedia.org/wiki/Dopamine_agonist

    Dopamine is a prolactin-inhibiting factor (PIFs) since it lowers the prolactin-releasing factors (PRFs) synthesis and secretion through D 2-like receptors. [11] That is why dopamine agonists are the first-line treatment in hyperprolactinaemia . [ 12 ]

  4. Cabergoline - Wikipedia

    en.wikipedia.org/wiki/Cabergoline

    Cabergoline is a long-acting dopamine D 2 receptor agonist. In-vitro rat studies show a direct inhibitory effect of cabergoline on the prolactin secretion in the lactotroph cells of the pituitary gland and cabergoline decreases serum prolactin levels in reserpinized rats.

  5. Bromocriptine - Wikipedia

    en.wikipedia.org/wiki/Bromocriptine

    Bromocriptine, originally marketed as Parlodel and subsequently under many brand names, [1] is an ergoline derivative and dopamine agonist that is used in the treatment of pituitary tumors, Parkinson's disease, hyperprolactinaemia, neuroleptic malignant syndrome, and, as an adjunct, type 2 diabetes.

  6. List of dopaminergic drugs - Wikipedia

    en.wikipedia.org/wiki/List_of_dopaminergic_drugs

    Dopamine receptors are a class of G protein-coupled receptors that are prominent in the vertebrate central nervous system (CNS) and are implicated in many neurological processes, including motivational and incentive salience, cognition, memory, learning, and fine motor control, as well as modulation of neuroendocrine signaling.

  7. Hyperprolactinaemia - Wikipedia

    en.wikipedia.org/wiki/Hyperprolactinaemia

    Dopamine acts on pituitary lactotroph D 2 receptors to inhibit prolactin secretion while other peptides and hormones, such as thyrotropin releasing hormone (TRH), stimulate prolactin secretion. [3] As a result, hyperprolactinemia may be caused by disinhibition (e.g., compression of the pituitary stalk or reduced dopamine levels) or excess ...

  8. Dopamine - Wikipedia

    en.wikipedia.org/wiki/Dopamine

    Once in the synapse, dopamine binds to and activates dopamine receptors. [38] These can be postsynaptic dopamine receptors, which are located on dendrites (the postsynaptic neuron), or presynaptic autoreceptors (e.g., the D 2 sh and presynaptic D 3 receptors), which are located on the membrane of an axon terminal (the presynaptic neuron).

  9. Prolactin receptor - Wikipedia

    en.wikipedia.org/wiki/Prolactin_receptor

    Dopamine agonists are currently the most common methods used for treating hyperprolactinemia. However, since dopamine agonists only negatively regulate prolactin production from the pituitary gland, a few studies have tried to develop prolactin receptor antagonists for potentially treating the dopamine-resistant local hyperprolactinemia.